Young Li
Stock Analyst at Jefferies
(0.53)
# 4,001
Out of 5,122 analysts
8
Total ratings
40%
Success rate
-13.59%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintains: Buy | $28 → $22 | $18.15 | +18.46% | 1 | Jan 28, 2026 | |
| TMDX TransMedics Group | Initiates: Buy | $145 | $135.72 | +6.84% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $8.34 | +7.91% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $79.33 | +44.96% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.13 | +10.62% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $21.79 | +175.36% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $10.02 | +359.08% | 1 | Jul 16, 2021 |
STAAR Surgical Company
Jan 28, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $18.15
Upside: +18.46%
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $135.72
Upside: +6.84%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $8.34
Upside: +7.91%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $79.33
Upside: +44.96%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.13
Upside: +10.62%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $21.79
Upside: +175.36%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $10.02
Upside: +359.08%